These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 12192418)

  • 21. Manic behaviors associated with fluoxetine in three 12- to 18-year-olds with obsessive-compulsive disorder.
    Go FS; Malley EE; Birmaher B; Rosenberg DR
    J Child Adolesc Psychopharmacol; 1998; 8(1):73-80. PubMed ID: 9639082
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Suicide risk and efficacy of antidepressant drugs--reply.
    Gibbons RD; Brown CH; Hur K; Davis JM; Mann JJ
    JAMA Psychiatry; 2013 Jan; 70(1):123-5. PubMed ID: 23303376
    [No Abstract]   [Full Text] [Related]  

  • 23. Short-term fluoxetine monotherapy for bipolar type II or bipolar NOS major depression - low manic switch rate.
    Amsterdam JD; Shults J; Brunswick DJ; Hundert M
    Bipolar Disord; 2004 Feb; 6(1):75-81. PubMed ID: 14996144
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Duloxetine-induced hypomania: case report and brief review of the literature on SNRIs-induced mood switching.
    Peritogiannis V; Antoniou K; Mouka V; Mavreas V; Hyphantis TN
    J Psychopharmacol; 2009 Jul; 23(5):592-6. PubMed ID: 18562441
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of fluoxetine, olanzapine, and combined fluoxetine plus olanzapine initial therapy of bipolar type I and type II major depression--lack of manic induction.
    Amsterdam JD; Shults J
    J Affect Disord; 2005 Jul; 87(1):121-30. PubMed ID: 15923042
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A 24-week open-label extension study of olanzapine-fluoxetine combination and olanzapine monotherapy in the treatment of bipolar depression.
    Corya SA; Perlis RH; Keck PE; Lin DY; Case MG; Williamson DJ; Tohen MF
    J Clin Psychiatry; 2006 May; 67(5):798-806. PubMed ID: 16841630
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mania following antidepressant discontinuation in depression: two case reports.
    Kwok CSN; Lim LEC
    Australas Psychiatry; 2017 Dec; 25(6):617-621. PubMed ID: 28976215
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A case of mania induced by high-dose fluoxetine treatment.
    Chouinard G; Steiner W
    Am J Psychiatry; 1986 May; 143(5):686. PubMed ID: 3485926
    [No Abstract]   [Full Text] [Related]  

  • 29. First manic/hypomanic episode in obsessive-compulsive disorder patients treated with antidepressants: A systematic review.
    Bertolín S; Alonso P; Segalàs C; Real E; Alemany-Navarro M; Soria V; Jiménez-Murcia S; Crespo JM; Menchón JM
    J Psychiatr Res; 2021 May; 137():319-327. PubMed ID: 33744511
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [SWITCH TO MANIC EPISODE WITH MIXED FEATURES IN DEPRESSIVE SOLDIER UNDER ANTIDEPRESSANT TREATMENT].
    Kalla C
    Harefuah; 2020 Jul; 159(7):483-485. PubMed ID: 32720764
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of mania with serotonin reuptake inhibitors.
    Howland RH
    J Clin Psychopharmacol; 1996 Dec; 16(6):425-7. PubMed ID: 8959466
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction of mania with selective serotonin re-uptake inhibitors and tricyclic antidepressants.
    Peet M
    Br J Psychiatry; 1994 Apr; 164(4):549-50. PubMed ID: 8038948
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Serotonergic syndrome--in combination therapy with lithium and fluoxetine].
    Karle J; Bjørndal F
    Ugeskr Laeger; 1995 Feb; 157(9):1204-5. PubMed ID: 7701669
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 'Use of selective serotonin reuptake inhibitors in children with pervasive developmental disorder: risk of treatment emergent mania'.
    Bates G; Willson SW
    Dev Med Child Neurol; 2003 May; 45(5):359; author reply 360. PubMed ID: 12729153
    [No Abstract]   [Full Text] [Related]  

  • 35. [For some it is a matter of necessity. Worry about the overuse of an antidepressant].
    Behnke K
    Nord Med; 1998 Jun; 113(6):191. PubMed ID: 9652162
    [No Abstract]   [Full Text] [Related]  

  • 36. Efficacy of usual antidepressant dosing regimens of fluoxetine in panic disorder: randomised, placebo-controlled trial.
    Michelson D; Allgulander C; Dantendorfer K; Knezevic A; Maierhofer D; Micev V; Paunovic VR; Timotijevic I; Sarkar N; Skoglund L; Pemberton SC
    Br J Psychiatry; 2001 Dec; 179():514-8. PubMed ID: 11731354
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Side effects of long-term treatment with fluoxetine.
    Buchman N; Strous RD; Baruch Y
    Clin Neuropharmacol; 2002; 25(1):55-7. PubMed ID: 11852298
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Antipsychotics in bipolar disorders].
    Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
    Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical risk factors and serotonin transporter gene variants associated with antidepressant-induced mania.
    Frye MA; McElroy SL; Prieto ML; Harper KL; Walker DL; Kung S; Chauhan M; Crow S; Sutor B; Galardy CW; Veldic M; Palmer BA; Geske JR; Fuentes M; Cuellar-Barboza AB; Seymour LR; Mori N; Biernacka JM
    J Clin Psychiatry; 2015 Feb; 76(2):174-80. PubMed ID: 25611077
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Onset of psoriasis during therapy with fluoxetine.
    Tan Pei Lin L; Kwek SK
    Gen Hosp Psychiatry; 2010; 32(4):446.e9-446.e10. PubMed ID: 20633754
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.